Trial Profile
A 12-week, Multi-center, Randomized, Double Blinded, Parallel Group, Placebo-controlled Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs SOTB 07 (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors SK Chemicals
- 27 Jan 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 Dec 2015 New trial record